Zacks Research Forecasts Editas Medicine FY2027 Earnings
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Zacks Research issued their FY2027 earnings per share (EPS) estimates for Editas Medicine in a report released on Wednesday, March 26th. Zacks Research analyst A. Chakraborty anticipates that the company will post earnings of ($2.30) per share for the year. The consensus estimate for Editas Medicine’s current […]
